Argentine-developed Covid vax ready to move on to trial phase

Argentine researchers are about to complete de development of the 'ARVAC Cecilia Grierson' Covid-19 vaccine, which is why volunteers are needed for the 2/3 trial phase, it was reported in Buenos Aires. The new drug is expected to be cleared by mid-2023.

Related Keywords

Buenos Aires ,Distrito Federal ,Argentina ,Argentine ,Cecilia Grierson ,Pablo Cassar ,Juliana Cassataro ,National Council Of Scientific ,National University Of San Mart ,Technical Research Conicet ,National Administration Of Medicines ,Ministry Of Science ,Argentine Developed Covid ,National Administration ,Medical Technology ,National Council ,Technical Research ,National University ,San Mart , ,